Franciscan Missionaries of Our Lady Health System
Questions or Suggestions
Drug Information Questions
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
Hazardous Drugs
Do Not Crush
Therapeutic Interchange
Do Not Tube-LALK
Do Not Tube-LACH
Restricted
CMS Self-Administered Drug Exclusion List
Look Alike Sound Alike Drugs
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
News
Boards
*COVID-19 Pharmacy Resources
Franciscan Missionaries of Our Lady Health System
Questions or Suggestions
Drug Information Questions
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
Hazardous Drugs
Do Not Crush
Therapeutic Interchange
Do Not Tube-LALK
Do Not Tube-LACH
Restricted
CMS Self-Administered Drug Exclusion List
Look Alike Sound Alike Drugs
Webpage Links
Search results for:
inotuzumab ozogamicin
inotuzumab ozogamicin
Brand names:
Besponsa
Form
Strength
ANAN
ASMP
LACH
LALK
LOHH
LOLR
LOWC
SDSD
SESE
SFSF
Formulary Status
POWDER FOR INJECTION, INTRAVENOUS
0.9 mg
non-formulary
VIEW MORE
Monoclonal Antibodies
,
Antineoplastic Agents
CLASS
081824
,
100000
Last updated:
Feb. 27, 2024
Black Box Warning:
Hepatotoxicity, Including Hepatic Veno-Occlusive Disease (VOD - also known as Sinusoidal Obstruction Syndrome) and Increased Risk of Post-Hematopoietic Stem Cell Transplant (HSCT) Non-Relapse Mortality
Hazardous Drugs:
View Hazardous Waste List
UpToDate
FDA Package Inserts